EP0468026A1 - Vitroceramique apatite. - Google Patents

Vitroceramique apatite.

Info

Publication number
EP0468026A1
EP0468026A1 EP91903842A EP91903842A EP0468026A1 EP 0468026 A1 EP0468026 A1 EP 0468026A1 EP 91903842 A EP91903842 A EP 91903842A EP 91903842 A EP91903842 A EP 91903842A EP 0468026 A1 EP0468026 A1 EP 0468026A1
Authority
EP
European Patent Office
Prior art keywords
apatite
glass ceramic
ceramic according
apatite glass
glass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP91903842A
Other languages
German (de)
English (en)
Other versions
EP0468026B1 (fr
Inventor
Carsten Jana
Wolfram Hoeland
Werner Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Original Assignee
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte filed Critical Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Publication of EP0468026A1 publication Critical patent/EP0468026A1/fr
Application granted granted Critical
Publication of EP0468026B1 publication Critical patent/EP0468026B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
    • A61L24/0084—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
    • A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A61K6/889—Polycarboxylate cements; Glass ionomer cements
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C10/00—Devitrified glass ceramics, i.e. glass ceramics having a crystalline phase dispersed in a glassy phase and constituting at least 50% by weight of the total composition
    • C03C10/16—Halogen containing crystalline phase
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass

Definitions

  • the invention relates to an apatite glass ceramic which, owing to its properties as a biomaterial in medicine and in particular in stomatology, can be used as an inorganic component for glass ionomer cements.
  • Apatite-containing glass ceramics and apatite sintered ceramics are known and are e.g. in DD 219 017 and in DD 245 864. Such biomaterials form direct bonds to living bones.
  • Glass ionomer cements As an inorganic component for glass ionomer cements, however, special requirements are placed on glass ceramics. Apatite-containing glass ceramics for glass ionomer cements have not yet been developed. Glass ionomer cements are created by mixing pluoralumosilicate glass powder and polymeric carboxylic acids. Glass ionomer cements are used in stomatology for suitable indications such as underfilling, core build-up and fastening.
  • a sole combination of fluoroaluminosilicate glass powders with polyacrylic acid results in glass ionomer cements with poor processing properties.
  • the glass ionomer cement takes too much time to set completely, so that its surface becomes brittle due to saliva contact in the patient's mouth.
  • Japanese Patent 52 (1977) 101 893 discloses an aqueous polyacrylic acid or acrylic polymer solution which contains one or more polybasic carboxylic acids. By Using this liquid, shorter setting times and higher mechanical strengths were achieved.
  • US Pat. No. 4,360,605 discloses a hardening liquid which contains tartaric acid in addition to an acrylic acid copolymer. It was found that this further improved the ratio of processing time to setting time. In the case of glass ionomer cements, the processing time should be long and the setting time as short as possible. In this regard, these glass ionomer cements do not yet meet the requirements of the user.
  • the setting process in glass ionomer cements is characterized by the formation of calcium and aluminum polycarboxylates.
  • Calcium polycarboxylate which is still relatively water-sensitive, forms in the first reaction step, only the formation of aluminum polycarboxylate, which occurs later due to the higher degree of order and the lower migration rate of the more highly charged aluminum ions, leads to the stable cement system.
  • Fluoroaluminosilicate glass powder of the system SiO 2 -Al 2 O 3 -CaO- 2 O 5 -Na 2 O-F ⁇ according to US Pat. No. 4,376,835 has the disadvantage that flexural strength and adhesion to the tooth structure are insufficient.
  • Strontium-containing fluoroaluminosilicate glass powders according to DE-A 3 804 469 show improved properties with regard to solubility and X-ray visibility, but have insufficient flexural strength and adhesion to the tooth structure.
  • Wilson and co-workers (Ind. Eng. Che. Prod. Res. Dev. 19, 1980, 263-270) examined glasses in which CaF2 crystals had formed in a side process. It was found that these glasses have a lower mechanical strength than the corresponding clear glasses.
  • Object of the invention is to develop an apatite-containing glass ceramics especially for glass ionomer cement, which improves handling and liability to known technical solutions of glass ionomer cements.
  • apatite glass ceramic has the composition
  • R2O is alkali oxide - preferably a2 ⁇ - and contains the glass phase and apatite in addition to the glass phase.
  • Apatite is preferably contained as the main crystal phase. It can also contain, for example, sillimanite, cristobalite and fluorite. Sillimanit and Cristo ⁇ balit can also form the main crystal phase.
  • Additional components such as SrO, FeO, Fe2 ⁇ 3, La 2 0 3 , Ti0 2 can also be up to 25% by mass individually or in a mixture. The additional components are added to the glass ceramic with regard to such properties as coloring,
  • composition is preferably as follows:
  • composition is particularly preferred as follows:
  • the apatite glass ceramic preferably contains a maximum of 8% by mass, in particular a maximum of 5% by mass ⁇ 2 o.
  • the apatite crystal phase increases mechanical strength and stimulates bone growth.
  • the apatite glass ceramic according to the invention preferably contains fluorapatite, but also hydroxylapatite or mixed fluoro-hydroxylapatite.
  • Sodium ions and / or potassium ions and / or aluminum ions and / or strontium ions can also be incorporated into these apatite phases.
  • the glass ceramic material according to the invention is produced from a starting glass which is melted at 1450 ° C. to 1600 ° C. It was surprisingly found that the glasses have droplet-shaped segregation regions, often with multiple segregation, and that apatite crystals separate during subsequent heat treatment. This is all the more astonishing, since in other composition ranges a controlled separation of apatite crystals via an amorphous / amorphous phase separation cannot be realized.
  • the starting glass is cooled to below the transformation temperature or is subjected to controlled crystallization directly from the melt.
  • the controlled one Crystallization takes place by thermal treatment of the glasses in one stage in the temperature range 700 ° C to 1150 ° C.
  • the crystallization process of the starting glass to form the glass ceramic according to the invention is controlled by specifically influencing the phase separation of the glasses.
  • Apatite crystals are separated from the glass from Ca2 + - p 2 ⁇ 5-F ⁇ -rich droplet-shaped primary demixing areas.
  • the volume fraction, number and size of these segregation zones can be set by selecting the chemical composition, the melting conditions and the thermal treatment, so that the volume fraction and crystal size of the apatite phase can be controlled.
  • the apatite crystals of the apatite glass ceramic preferably have a crystal size of 0.2 to 3 ⁇ m.
  • a powder of glass ceramic is used, the powder grains preferably having an average grain size (weight average) of at least 1 ⁇ m and preferably at least 3 ⁇ m.
  • the average grain size (weight average) is 1 to 20 ⁇ m, preferably 3 to 15 ⁇ m and particularly preferably 3 to 10 ⁇ m.
  • the particles have a maximum grain size of 150 ⁇ m, preferably 100 ⁇ m, particularly 60 ⁇ m.
  • the glass ionomer cement is produced by curing this glass ceramic powder and a polyacid in the presence of water and optionally other conventional additives, such as tartaric acid.
  • the powders thus obtained are then optionally subjected to a surface treatment in accordance with European patent specification 0 023 013.
  • the glass powders are surface-treated with acid, preferably at room temperature.
  • Substances containing acidic groups are used, for example hydrochloric acid, sulfuric acid, nitric acid, acetic acid, propionic acid or per- Chloric acid, which form common calcium salts or strontium salts.
  • the acids are used in a concentration of 0.01 to 10% by weight, preferably 0.05 to 3% by weight. After the corresponding reaction time, the powders are separated from the solution and washed out thoroughly, so that there are practically no soluble calcium or strontium salts on the surface of the powder particles.
  • the polyacids known in connection with glass ionomer cement can be used as polyacids, e.g. Polymalic acid, polyacrylic acid, polyitaconic acid and a mixture thereof or copolymers, in particular the maleic acid-acrylic acid copolymers and / or acrylic acid-itaconic acid copolymers known from EP-B-0 024 056.
  • the average molecular weight of the polycarboxylic acids to be used according to the invention is more than 500. An average molecular weight of 1,000 to 20,000 is advantageous, 3,000 to 10,000 being particularly preferred.
  • the polycarboxylic acid is preferably used in concentrations of 5 to 50% by weight, based on the weight of the apatite glass ceramic.
  • polyphosphonic acids e.g. Polyvinyl phosphonic acid. These polyphosphonic acids can replace the above-mentioned polycarboxylic acids in whole or in part.
  • glass ionomer cements made from apatite glass ceramic powder have better processing properties, rapid hardening and increased mechanical strength.
  • the presence of the apatite crystal phase results in better adhesion of the glass ionomer cement to the tooth structure.
  • Table 1 An overview of the compositions in mass% of the apatite glass ceramic according to the invention and their starting glasses is given in Table 1.
  • Table 2 contains selected ones Examples which show the relationship between chemical composition, thermal treatment of the starting glasses and crystal phase, crystal size.
  • the glass ceramic of Example 16 which was thermally treated according to Table 2, was ground to a fine powder with an average grain size of 6.2 ⁇ m (weight average); the maximum grain size was 40 ⁇ m.
  • the cement mixture obtained was plastically deformable at 33 ° C. room temperature for 3 minutes and 15 seconds (processing time) and hardened after only 3 minutes and 20 seconds (hardening time), in each case calculated from the start of mixing.
  • the flexural strength was 39.7 MPa.
  • Example 17 was ground to a fine powder with an average grain size of 7.8 ⁇ m (weight average); the maximum grain size was 45 ⁇ m.
  • the cement mixture obtained had a processing time of 2 min 40 sec and a setting time of only 3 min 55 sec at room temperature of 23 ° C., in each case calculated from the beginning of the mixing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Geochemistry & Mineralogy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Ceramic Engineering (AREA)
  • Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Glass Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dental Preparations (AREA)

Abstract

L'invention concerne une vitrocéramique apatite pouvant s'utiliser en médecine comme biomatière et, de ce fait, constituer le composant anorganique de vitrociments ionomères. La vitrocéramique apatite consiste en (en % de matière) 15-40 SiO2, 15-35 Al2O3, 12-30 CaO, 6-25 P2O5, 2,5-15F-, 0-18 R2O où R2O est un oxyde alcalin et contient la phase cristalline apatite.
EP91903842A 1990-02-12 1991-02-11 Vitroceramique apatite Expired - Lifetime EP0468026B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DD90337765A DD291982A5 (de) 1990-02-12 1990-02-12 Apatitglaskeramik, vorzugsweise fuer dentale glasionomerzemente
DD337765 1990-02-12
PCT/EP1991/000265 WO1991012212A1 (fr) 1990-02-12 1991-02-11 Vitroceramique apatite

Publications (2)

Publication Number Publication Date
EP0468026A1 true EP0468026A1 (fr) 1992-01-29
EP0468026B1 EP0468026B1 (fr) 1994-11-17

Family

ID=5616397

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91903842A Expired - Lifetime EP0468026B1 (fr) 1990-02-12 1991-02-11 Vitroceramique apatite

Country Status (7)

Country Link
US (1) US5318929A (fr)
EP (1) EP0468026B1 (fr)
JP (1) JPH04505445A (fr)
AT (1) ATE114145T1 (fr)
DD (1) DD291982A5 (fr)
DE (1) DE59103529D1 (fr)
WO (1) WO1991012212A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2245559A (en) * 1990-06-25 1992-01-08 Farmos Oy Bioceramic system for delivery of a bioactive compound.
DE69214005T2 (de) * 1991-05-01 1997-05-15 Chichibu Onoda Cement Corp Erhärtende Zusammensetzungen zur Verwendung in der Medizin oder Zahnheilkunde
US5344640A (en) * 1991-10-22 1994-09-06 Mallinckrodt Medical, Inc. Preparation of apatite particles for medical diagnostic imaging
US5407659A (en) * 1991-10-22 1995-04-18 Mallinckrodt Medical, Inc. Treated calcium/oxyanion-containing particles for medical diagnostic imaging
DE4423793C1 (de) 1994-07-01 1996-02-22 Ivoclar Ag Leucithaltige Phosphosilikat-Glaskeramik, Verfahren zu deren Herstellung und deren Verwendung
DE59711025D1 (de) * 1996-09-30 2003-12-24 Degudent Gmbh Polymerisierbarer Dentalwerkstoff und Verwendung von Apatit-Füllstoffen im Dentalwerkstoff
DE69820863T2 (de) * 1997-04-03 2004-12-09 Corning Inc. Durchsichtige apatit glaskeramik
US6200137B1 (en) * 1997-06-12 2001-03-13 Ivoclar Ag Chemically stable translucent apatite glass ceramic
US6280863B1 (en) * 1997-06-12 2001-08-28 Ivoclar Ag Translucent apatite glass ceramic
DE19726103A1 (de) * 1997-06-19 1998-12-24 Muehlbauer Ernst Kg Alumofluorosilicatglas
DE10340597B4 (de) * 2003-09-01 2007-11-08 Ivoclar Vivadent Ag Transluzente und radio-opake Glaskeramiken, Verfahren zu ihrer Herstellung und ihre Verwendung
US8715625B1 (en) 2010-05-10 2014-05-06 The Clorox Company Natural oral care compositions
GB201010758D0 (en) * 2010-06-25 2010-08-11 Queen Mary & Westfield College Bioactive glass composition
EP3079645B1 (fr) 2013-12-12 2022-02-16 3M Innovative Properties Company Ciment de verre ionomère, procédé de production et d'utilisation de celui-ci
CN105439451B (zh) * 2014-08-27 2018-03-27 济南大学 一种羟基磷灰石结晶玻璃及其制备方法
CN105366942B (zh) * 2014-08-27 2018-03-27 济南大学 一种羟基磷灰石微晶玻璃及其制备方法
US10548818B2 (en) 2015-07-21 2020-02-04 3M Innovative Properties Company Kit of parts for producing a glass ionomer cement, process of production and use thereof
CN105712736B (zh) * 2016-01-29 2019-07-16 昆明理工大学 一种多孔羟基磷灰石/氧化锶复合骨修复材料的制备方法
EP3263089A1 (fr) 2016-06-30 2018-01-03 Dentsply DeTrey GmbH Composition dentaire comprenant un remplissage dentaire contenant une charge structurelle et des flocons de verre silanisé
EP3300714A1 (fr) 2016-09-30 2018-04-04 DENTSPLY DETREY GmbH Composition dentaire
EP3336092A1 (fr) 2016-12-14 2018-06-20 DENTSPLY DETREY GmbH Composition dentaire
EP3335689A1 (fr) 2016-12-14 2018-06-20 DENTSPLY DETREY GmbH Composition dentaire
EP3338757A1 (fr) 2016-12-20 2018-06-27 Dentsply DeTrey GmbH Composition de remplissage dentaire direct
EP3449895A1 (fr) 2017-08-30 2019-03-06 Dentsply DeTrey GmbH Polymère polyacide modifié par un photoinitiateur
AU2018326543B2 (en) 2017-08-30 2022-03-03 Dentsply Detrey Gmbh Photoinitiator modified polyacidic polymer
EP3449894A1 (fr) 2017-08-31 2019-03-06 Dentsply DeTrey GmbH Composition dentaire comprenant un support particulaire portant un co-initiateur
EP3536303A1 (fr) 2018-03-07 2019-09-11 Dentsply DeTrey GmbH Composition dentaire
EP3650004A1 (fr) 2018-11-08 2020-05-13 Dentsply DeTrey GmbH Composition dentaire durcissable à deux constituants
EP3653194A1 (fr) 2018-11-15 2020-05-20 Dentsply DeTrey GmbH Coinitiateurs bifonctionnels et polyfonctionnels dans des compositions dentaires
EP3659546B1 (fr) 2018-11-27 2022-10-19 Dentsply DeTrey GmbH Procédé de fabrication additive

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3814717A (en) * 1970-12-04 1974-06-04 Dental Materials Section Labor Poly(carboxylic acid)-fluoroalumino-silicate glass surgical cement
JPS52101893A (en) * 1976-02-24 1977-08-26 Nippon Kayaku Kk Liquid hardener for dental glass ionomer cement
DE2929121A1 (de) * 1979-07-18 1981-02-12 Espe Pharm Praep Calciumaluminiumfluorosilikatglas- pulver und seine verwendung
DE2932823A1 (de) * 1979-08-13 1981-03-12 Espe Pharm Praep Anmischkomponente fuer glasionomerzemente
DE3248357A1 (de) * 1982-12-28 1984-07-05 ESPE Fabrik pharmazeutischer Präparate GmbH, 8031 Seefeld Pulverfoermiger dentalwerkstoff, verfahren zu seiner herstellung und seine verwendung
JPS6069007A (ja) * 1983-09-26 1985-04-19 Kyocera Corp 人工歯冠及びその製造法
US4643982A (en) * 1984-12-05 1987-02-17 Hoya Corporation High-strength glass-ceramic containing anorthite crystals and process for producing the same
JPH0755882B2 (ja) * 1987-02-13 1995-06-14 而至歯科工業株式会社 歯科用グラスアイオノマーセメント用ガラス粉末
US4960733A (en) * 1987-02-28 1990-10-02 Hoya Corporation Inorganic biomaterial and process for producing the same
DE3907663A1 (de) * 1989-03-09 1990-09-13 Espe Stiftung Knochenersatzteil aus glasionomerzement

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9112212A1 *

Also Published As

Publication number Publication date
JPH04505445A (ja) 1992-09-24
ATE114145T1 (de) 1994-12-15
EP0468026B1 (fr) 1994-11-17
US5318929A (en) 1994-06-07
DE59103529D1 (en) 1994-12-22
DD291982A5 (de) 1991-07-18
WO1991012212A1 (fr) 1991-08-22

Similar Documents

Publication Publication Date Title
EP0468026B1 (fr) Vitroceramique apatite
DE69214005T2 (de) Erhärtende Zusammensetzungen zur Verwendung in der Medizin oder Zahnheilkunde
EP0690030B1 (fr) Vitrocéramique de phosphosilicate avec du leucite
DE3628822C2 (fr)
EP0695726B1 (fr) Vitrocéramiques et verre de silicate d'alkali et de zinc
EP1343452B1 (fr) Verre dentaire peu reactif
EP2662343B1 (fr) Vitrocéramique et verre au lithium-silice ayant une teneur en ZrO2
EP2792345B1 (fr) Vitrocéramique et verre au lithium-silice ayant une teneur en oxyde de césium
EP2114348B1 (fr) Céramique pour incrustations vestibulaires pour des restaurations dentaires en dioxyde de zirconium stabilisé à l'yttrium et procédé de fixation d'incrustations vestibulaires sur des restaurations dentaires en dioxyde de zirconium stabilisé à l'yttrium
DE2750326C3 (de) Härtbare Zementmischung für medizinische Zwecke
EP0469573B1 (fr) Composition déformable et leur utilisation pour remplissage des canaux dentaires
DE2547744B2 (de) Durch Wasserzusatz selbsthärtendes Zementpulvergemisch
EP2765975A2 (fr) Vitrocéramique et verre en silicate de lithium, ayant un oxyde métallique trivalent
EP1720806B1 (fr) Verre opaque aux rayons x, son procede de fabrication et son utilisation
DE3710200A1 (de) Alkalifreie, biovertraegliche glaskeramik
EP2765976A2 (fr) Vitrocéramique et verre en silicate de lithium, ayant un oxyde métallique tétravalent
DE3806215A1 (de) Anorganisches biomaterial und verfahren zu dessen herstellung
DE102004050095A1 (de) Ca0-Mg0-Si02-basiertes, biologisch aktives Glas und gesintertes Calciumphosphat-Glas
DE10332086A1 (de) Ca0-Si02-basiertes bioaktives Glas und gesintertes Calciumphosphat-Glas
EP0541546B1 (fr) Matiere vitreuse ou vitreuse-cristalline a solubilite rapide et procede pour sa fabrication
WO1997034847A1 (fr) Vitroceramiques micaciques translucides a resistance elevee
WO1990000893A1 (fr) Materiau dentaire pulverulent, son procede de fabrication et son utilisation
EP1413321B1 (fr) Matériau pour prothèse osseuse à base de phosphate comprenant des phases cristallines et amorphes
EP1266874A1 (fr) Matière vitreuse-cristalline de faible solubilité et son procédé de réalisation
DE102019120434A1 (de) Glaszusammensetzung und Glaspulver, insbesondere zur Verwendung im Dentalbereich

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT CH DE ES FR GB IT LI

17P Request for examination filed

Effective date: 19920120

17Q First examination report despatched

Effective date: 19940119

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT CH DE ES FR GB IT LI

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19941117

REF Corresponds to:

Ref document number: 114145

Country of ref document: AT

Date of ref document: 19941215

Kind code of ref document: T

REF Corresponds to:

Ref document number: 59103529

Country of ref document: DE

Date of ref document: 19941222

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19941205

ITF It: translation for a ep patent filed
ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19970129

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19970204

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 19970210

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19970219

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19970227

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980211

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980228

Ref country code: FR

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 19980228

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19980228

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19980211

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19981103

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050211